MedPath

Efficacy of physiotherapy after hydrodilatation for the painful stiff shoulder: a randomised placebo-controlled trial

Completed
Conditions
Adhesive Capsulitis
Physical Medicine / Rehabilitation - Physiotherapy
Physical Medicine / Rehabilitation - Pain management
Registration Number
ACTRN12605000685617
Lead Sponsor
The Monash Department of Clinical Epidemiology at Cabrini Hospital and Department of Epidemiology and Epidemiology, Monash University initiated and managed the trial.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
150
Inclusion Criteria

i) symptoms of pain and stiffness in predominantly one shoulder for > 3 months; ii) restriction of passive motion of greater than 30o in two or more planes of movement, measured to onset of pain with a gravity inclinometer; iii) adults.

Exclusion Criteria

i) severe pain at rest, defined as > 7 out of 10 on a visual analogue scale; ii) systemic inflammatory joint disease (including rheumatoid arthritis, polymyalgia rheumatica); iii) radiological evidence of osteoarthritis of the shoulder or fracture; iv) calcification about the shoulder joint; v) reason to suspect a complete rotator cuff tear (weakness of arm elevation, a positive drop arm sign, a high riding humerus visible on x-ray of the shoulder or demonstration of a complete rotator cuff tear on ultrasound); vi) contraindications to arthrogram and/or hydrodilatation such as current warfarin therapy; allergy to local anaesthetic or iodinated contrast; vii) pregnancy; viii) likely not to attend for physiotherapy sessions or comply with follow up; ix) inability to partake in moderate exercise, x) previous post-hydrodilatation physiotherapy program; xi) lack of written informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Shoulder Pain and Disability Index (SPADI) is a self-administered shoulder-specific disability index consisting of 13 items divided into pain and disability subscales.[Measured as baseline, 6 weeks, 3 and 6 months. The primary endpoint was at 3 months.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath